Browsing: Medicare
Centene‘s stock has experienced a significant decline—more than 42% in the past six months—primarily due to the withdrawal of its…
It was a small anecdote, buried in a lengthy profile in The New Yorker of Commerce S Howard Lutnick, “Donald…
Injectable glucagon-like peptide-1 agonists, or GLP-1s, were first approved as diabetes medications 20 years ago. They’ve since become popular as…
Lawmakers have known for decades that U.S. entitlement programs are on unsustainable paths as demographics inevitably skew the population older.…
Physicians are paid 33.6% less for treating Medicare patients than a decade ago thanks to reimbursement cuts coupled by rising…
The federal budget deficits caused by President Donald Trump’s tax and spending law could trigger automatic cuts to Medicare if Congress does…
California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss. Other states are…
Top Trump administration health officials are expected to bring tech companies to the White House this week to roll out…
Since the pandemic struck the U.S., most Americans have developed a keen appreciation of their hospitals and an equal awareness…
With the skill of a veteran heart surgeon reassuring patients facing a life-changing procedure, Dr. Mehmet Oz projected calm continuity…